Richard I. Horowitz

“This is usually accomplished by taking X-rays of the affected joints and analyzing blood for an ANA and rheumatoid factor (RF). Unfortunately, Lyme disease can cause false positive ANAs and rheumatoid factors due to a patient’s overstimulated immune system. This can lead to a mistaken diagnosis of lupus or rheumatoid arthritis. This is why drawing a CCP (cyclic citrullinated peptide) is so important. It is a specific marker for rheumatoid arthritis and will help determine whether the patient has true rheumatoid arthritis or not. Patients with a positive ANA or RF often are prescribed immunosuppressive drugs, such as steroids or immunomodulatory drugs, like Enbrel or Arava. These treatments can have dire consequences for the Lyme disease patient who is co-infected, since they are already immune-suppressed, and steroids can cause their underlying infections and subsequent manifestations”
― Richard I. Horowitz, Why Can't I Get Better?: Solving the Mystery of Lyme & Chronic Disease

“Flagyl was clearly effective in the treatment of Lyme disease. But how did it work? As early as 1967 The British Journal of Venereal Diseases had published a study showing Flagyl to be effective in certain cases of syphilis, and that it had an effect on bacterial DNA and RNA irrespective of bacterial replication. Could this be the mechanism of Flagyl’s action against Burrelia burgdorferi? The key to Flagyl’s effectiveness on Lyme, however, was not reported until several months after my study was presented. Dr. O. Brorson, a Norwegian researcher, published a paper on Flagyl and its effect on the cystic forms of Lyme disease six months after I presented my research. The cystic form of Lyme disease, it turns out, is one mechanism that Borrelia burgdorferi utilizes to persist in the body. Dr. Brorson reported that Flagyl would cause Borrelia cysts to rupture, and he went on to publish that he could see under the microscope the cell wall forms of Borrelia burgdorferi (helical/spiral–shaped organisms) transform into cystic forms, and under proper conditions convert back into mobile spirochetes. A review of the medical literature revealed that these cystic forms had, in fact, been reported in syphilis. No one had clearly made the link between Borrelia and a cystic form of the organism that could persist for long periods of time in a dormant state. It was a highly evolved survival mechanism that would allow the organism to reemerge when conditions were optimal. My patient, Mary, had been treated initially with Plaquenil, which according to Dr. Brorson’s research also affects the cystic forms, yet it appeared that it was not powerful enough to destroy the dormant forms and prevent a relapse, or to prevent her from passing it on to her fetus. She had also been treated with drugs that addressed the cell wall and intracellular forms of Lyme. Although Plaquenil has some effect on cystic forms, it is often primarily used in antibiotic regimens with Lyme disease to alkalize the intracellular compartment, modulate autoimmune reactions, and affect essential enzymes necessary for bacterial replication. Clearly, however, it is not powerful enough to destroy enough of the”
― Richard I. Horowitz, Why Can't I Get Better?: Solving the Mystery of Lyme & Chronic Disease